Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia
Joëlle Choueiry, Crystal Blais, Dhrasti Shah, et al.
International Journal of Psychophysiology (2019) Vol. 145, pp. 70-82
Closed Access | Times Cited: 20

Showing 20 citing articles:

α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
Alvin V. Terry, Patrick M. Callahan
Neuropharmacology (2020) Vol. 170, pp. 108053-108053
Open Access | Times Cited: 71
Temporal imprecision of phase coherence in schizophrenia and psychosis—dynamic mechanisms and diagnostic marker
Annemarie Wolff, Georg Northoff
Molecular Psychiatry (2024) Vol. 29, Iss. 2, pp. 425-438
Closed Access | Times Cited: 14
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Ramón Cacabelos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3059-3059
Open Access | Times Cited: 48
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 41
The role of rodent behavioral models of schizophrenia in the ongoing search for novel antipsychotics
Hugo Cano-Ramírez, Kurt L. Hoffman
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access
Treating disorders across the lifespan by modulating cholinergic signaling with galantamine
Christine N. Metz, Valentin A. Pavlov
Journal of Neurochemistry (2020) Vol. 158, Iss. 6, pp. 1359-1380
Open Access | Times Cited: 38
It’s in the timing: reduced temporal precision in neural activity of schizophrenia
Annemarie Wolff, Javier Gómez‐Pilar, Jianfeng Zhang, et al.
Cerebral Cortex (2021) Vol. 32, Iss. 16, pp. 3441-3456
Open Access | Times Cited: 28
Left posterior superior temporal gyrus and its structural connectivity in schizophrenia
Hitoshi Sasaki, Manabu Kubota, Jun Miyata, et al.
Psychiatry Research Neuroimaging (2025) Vol. 347, pp. 111947-111947
Closed Access
Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions
Stephen I. Deutsch, Jessica A. Burket
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 104, pp. 110017-110017
Closed Access | Times Cited: 28
Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects
Britta Hahn, Megan E. Shrieves, Cory K. Olmstead, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 219-230
Open Access | Times Cited: 19
Cholinergic modulation of sensory perception and plasticity
Ansley J. Kunnath, René H. Gifford, Mark T. Wallace
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105323-105323
Open Access | Times Cited: 4
Auditory Sensory Gating: Effects of Noise
Fan-Yin Cheng, Julia Campbell, Chang Liu
Biology (2024) Vol. 13, Iss. 6, pp. 443-443
Open Access | Times Cited: 1
An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine
Joëlle Choueiry, Crystal Blais, Dhrasti Shah, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 4, pp. 381-395
Open Access | Times Cited: 3
Increased noise relates to abnormal excitation-inhibition balance in schizophrenia: a combined empirical and computational study
Samira Abbasi, Annemarie Wolff, Yasir Çatal, et al.
Cerebral Cortex (2023) Vol. 33, Iss. 20, pp. 10477-10491
Open Access | Times Cited: 3
The neurophysiology of schizophrenia: Current update and future directions
Derek J. Fisher, Dean F. Salisbury
International Journal of Psychophysiology (2019) Vol. 145, pp. 1-4
Closed Access | Times Cited: 7
CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study
Joëlle Choueiry, Crystal Blais, Dhrasti Shah, et al.
Psychopharmacology (2020) Vol. 237, Iss. 12, pp. 3665-3687
Closed Access | Times Cited: 7
P50 sensory gating as a neurophysiological correlate of symptomatic improvement by virtual reality-based computer avatar therapy system in patients with auditory verbal hallucinations: A pilot study
Nana Liang, Xinrong Li, Xianju Guo, et al.
Schizophrenia Research (2023) Vol. 252, pp. 296-299
Closed Access | Times Cited: 1
Chemoreactom analysis of cytidyldiphosphocholine indicates synergistic combinations of neuroprotective agents
I. Yu. Torshin, О. А. Громова, L. A. Mayorova, et al.
Neurology neuropsychiatry Psychosomatics (2021) Vol. 13, Iss. 2, pp. 144-156
Open Access | Times Cited: 3
Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine by low-dose galantamine in rats
Britta Hahn, Carolyn H. Reneski, Malcom Lane, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173043-173043
Open Access | Times Cited: 2
Developmental Manipulation-Induced Changes in Cognitive Functioning
Sahith Kaki, Holly DeRosa, Brian Timmerman, et al.
Current topics in behavioral neurosciences (2022), pp. 241-289
Open Access
Page 1

Scroll to top